Ophthaine

   
Google
 
Web NewDrugInformation.com

Ophthaine


Drug - Ophthaine
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Proparacaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 0.5%
The potency of the active ingredient(s), Proparacaine Hydrochloride. May repeat for multiple part products.

Applicant - APOTHECON
The firm name holding legal responsibility for Ophthaine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 008883
The FDA assigned number to Ophthaine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ophthaine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Ophthaine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Ophthaine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ophthaine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Apothecon Inc Div Bristol Myers Squibb
The full name of the firm holding legal responsibility for the new application of Ophthaine.

Ophthaine